Latest Breaking News On - Diakonos oncology corp - Page 1 : comparemela.com

Diakonos Oncology s Unique Dendritic Cell Vaccine (DOC1021) Improves Survival Compared to Standard of Care in Phase 1 Trial for Glioblastoma | Region

HOUSTON (BUSINESS WIRE) Apr 9, 2024

United statesMike wicksJay hartenbachDiakonos oncology corpAmerican association for cancer researchOncology corpCancer researchFast trackOrphan drugDiakonos oncologyBusiness wire

Diakonos Oncology s Unique Dendritic Cell Vaccine (DOC1021) Improves Survival Compared to Standard of Care in Phase 1 Trial for Glioblastoma

Diakonos Oncology s Unique Dendritic Cell Vaccine (DOC1021) Improves Survival Compared to Standard of Care in Phase 1 Trial for Glioblastoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMike wicksDiakonos oncology corpAmerican association for cancer researchCancer researchOncology corpFast trackOrphan drugDiakonos oncology

Diakonos Oncology Names Paul Lammers, M D , Veteran BioPharma Senior Executive, to its Board of Directors

Diakonos Oncology Names Paul Lammers, M D , Veteran BioPharma Senior Executive, to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBaylor college of medicinePaul lammersAnderson cooperTriumvira immunologicsMike wicksUs product developmentDiakonos oncology corpChief executive officerMirna therapeuticsChief medical officerDiakonos oncologyBaylor college

Diakonos Oncology Names Ian H Bellayr, Ph D Chief Regulatory Officer

HOUSTON (BUSINESS WIRE) Nov 20, 2023

United statesIanh bellayrJay hartenbachMike wicksDiakonos oncology corporationNational institutes of healthBiotechnology branchDivision of cellularDrug administrationNational institute of diabetesUniversity of virginiaUniversity of pittsburghNational institute of allergyDiakonos oncology corpOncology corporationNational institutes

Diakonos Oncology Awarded FDA Fast Track Designation for Innovative Dendritic Cell Vaccine for Glioblastoma

Diakonos Oncology Awarded FDA Fast Track Designation for Innovative Dendritic Cell Vaccine for Glioblastoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of texasTexas medical centerUniversity of arizonaJoseph georgesWilliam deckerMike wicksDrug administrationDiakonos oncology corpUniversity of arizona college medicineUniversity of texas health science centerDiakonos oncology corporationOncology corporationFast trackChief executive officerAssociate professor